Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Pertussis Vaccination Market Growth 2022-2028

  • LP 4973572
  • 91 Pages
  • July 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Pertussis Vaccination will have significant change from previous year. According to our (LP Information) latest study, the global Pertussis Vaccination market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pertussis Vaccination market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Pertussis Vaccination market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Pertussis Vaccination market, reaching US$ million by the year 2028. As for the Europe Pertussis Vaccination landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Pertussis Vaccination players cover Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, and KM Biologics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Pertussis Vaccination market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Acellular Vaccines

Whole-cell Vaccines

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

12 Months Below

12 Months Above

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Sanofi Pasteur

GSK

Mitsubishi Tanabe Pharma

KM Biologics

Wuhan Institute of Biological Products

Walvax Biotechnology

Chengdu Institute of Biological Products

Minhai Biotechnology

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pertussis Vaccination Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Pertussis Vaccination by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Pertussis Vaccination by Country/Region, 2017, 2022 & 2028

2.2 Pertussis Vaccination Segment by Type

2.2.1 Acellular Vaccines

2.2.2 Whole-cell Vaccines

2.3 Pertussis Vaccination Sales by Type

2.3.1 Global Pertussis Vaccination Sales Market Share by Type (2017-2022)

2.3.2 Global Pertussis Vaccination Revenue and Market Share by Type (2017-2022)

2.3.3 Global Pertussis Vaccination Sale Price by Type (2017-2022)

2.4 Pertussis Vaccination Segment by Application

2.4.1 12 Months Below

2.4.2 12 Months Above

2.5 Pertussis Vaccination Sales by Application

2.5.1 Global Pertussis Vaccination Sale Market Share by Application (2017-2022)

2.5.2 Global Pertussis Vaccination Revenue and Market Share by Application (2017-2022)

2.5.3 Global Pertussis Vaccination Sale Price by Application (2017-2022)

3 Global Pertussis Vaccination by Company

3.1 Global Pertussis Vaccination Breakdown Data by Company

3.1.1 Global Pertussis Vaccination Annual Sales by Company (2020-2022)

3.1.2 Global Pertussis Vaccination Sales Market Share by Company (2020-2022)

3.2 Global Pertussis Vaccination Annual Revenue by Company (2020-2022)

3.2.1 Global Pertussis Vaccination Revenue by Company (2020-2022)

3.2.2 Global Pertussis Vaccination Revenue Market Share by Company (2020-2022)

3.3 Global Pertussis Vaccination Sale Price by Company

3.4 Key Manufacturers Pertussis Vaccination Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Pertussis Vaccination Product Location Distribution

3.4.2 Players Pertussis Vaccination Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Pertussis Vaccination by Geographic Region

4.1 World Historic Pertussis Vaccination Market Size by Geographic Region (2017-2022)

4.1.1 Global Pertussis Vaccination Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Pertussis Vaccination Annual Revenue by Geographic Region

4.2 World Historic Pertussis Vaccination Market Size by Country/Region (2017-2022)

4.2.1 Global Pertussis Vaccination Annual Sales by Country/Region (2017-2022)

4.2.2 Global Pertussis Vaccination Annual Revenue by Country/Region

4.3 Americas Pertussis Vaccination Sales Growth

4.4 APAC Pertussis Vaccination Sales Growth

4.5 Europe Pertussis Vaccination Sales Growth

4.6 Middle East & Africa Pertussis Vaccination Sales Growth

5 Americas

5.1 Americas Pertussis Vaccination Sales by Country

5.1.1 Americas Pertussis Vaccination Sales by Country (2017-2022)

5.1.2 Americas Pertussis Vaccination Revenue by Country (2017-2022)

5.2 Americas Pertussis Vaccination Sales by Type

5.3 Americas Pertussis Vaccination Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pertussis Vaccination Sales by Region

6.1.1 APAC Pertussis Vaccination Sales by Region (2017-2022)

6.1.2 APAC Pertussis Vaccination Revenue by Region (2017-2022)

6.2 APAC Pertussis Vaccination Sales by Type

6.3 APAC Pertussis Vaccination Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Pertussis Vaccination by Country

7.1.1 Europe Pertussis Vaccination Sales by Country (2017-2022)

7.1.2 Europe Pertussis Vaccination Revenue by Country (2017-2022)

7.2 Europe Pertussis Vaccination Sales by Type

7.3 Europe Pertussis Vaccination Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pertussis Vaccination by Country

8.1.1 Middle East & Africa Pertussis Vaccination Sales by Country (2017-2022)

8.1.2 Middle East & Africa Pertussis Vaccination Revenue by Country (2017-2022)

8.2 Middle East & Africa Pertussis Vaccination Sales by Type

8.3 Middle East & Africa Pertussis Vaccination Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Pertussis Vaccination

10.3 Manufacturing Process Analysis of Pertussis Vaccination

10.4 Industry Chain Structure of Pertussis Vaccination

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Pertussis Vaccination Distributors

11.3 Pertussis Vaccination Customer

12 World Forecast Review for Pertussis Vaccination by Geographic Region

12.1 Global Pertussis Vaccination Market Size Forecast by Region

12.1.1 Global Pertussis Vaccination Forecast by Region (2023-2028)

12.1.2 Global Pertussis Vaccination Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Pertussis Vaccination Forecast by Type

12.7 Global Pertussis Vaccination Forecast by Application

13 Key Players Analysis

13.1 Sanofi Pasteur

13.1.1 Sanofi Pasteur Company Information

13.1.2 Sanofi Pasteur Pertussis Vaccination Product Offered

13.1.3 Sanofi Pasteur Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Pasteur Main Business Overview

13.1.5 Sanofi Pasteur Latest Developments

13.2 GSK

13.2.1 GSK Company Information

13.2.2 GSK Pertussis Vaccination Product Offered

13.2.3 GSK Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GSK Main Business Overview

13.2.5 GSK Latest Developments

13.3 Mitsubishi Tanabe Pharma

13.3.1 Mitsubishi Tanabe Pharma Company Information

13.3.2 Mitsubishi Tanabe Pharma Pertussis Vaccination Product Offered

13.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Mitsubishi Tanabe Pharma Main Business Overview

13.3.5 Mitsubishi Tanabe Pharma Latest Developments

13.4 KM Biologics

13.4.1 KM Biologics Company Information

13.4.2 KM Biologics Pertussis Vaccination Product Offered

13.4.3 KM Biologics Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 KM Biologics Main Business Overview

13.4.5 KM Biologics Latest Developments

13.5 Wuhan Institute of Biological Products

13.5.1 Wuhan Institute of Biological Products Company Information

13.5.2 Wuhan Institute of Biological Products Pertussis Vaccination Product Offered

13.5.3 Wuhan Institute of Biological Products Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Wuhan Institute of Biological Products Main Business Overview

13.5.5 Wuhan Institute of Biological Products Latest Developments

13.6 Walvax Biotechnology

13.6.1 Walvax Biotechnology Company Information

13.6.2 Walvax Biotechnology Pertussis Vaccination Product Offered

13.6.3 Walvax Biotechnology Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Walvax Biotechnology Main Business Overview

13.6.5 Walvax Biotechnology Latest Developments

13.7 Chengdu Institute of Biological Products

13.7.1 Chengdu Institute of Biological Products Company Information

13.7.2 Chengdu Institute of Biological Products Pertussis Vaccination Product Offered

13.7.3 Chengdu Institute of Biological Products Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Chengdu Institute of Biological Products Main Business Overview

13.7.5 Chengdu Institute of Biological Products Latest Developments

13.8 Minhai Biotechnology

13.8.1 Minhai Biotechnology Company Information

13.8.2 Minhai Biotechnology Pertussis Vaccination Product Offered

13.8.3 Minhai Biotechnology Pertussis Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Minhai Biotechnology Main Business Overview

13.8.5 Minhai Biotechnology Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Pertussis Vaccination Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Pertussis Vaccination Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Acellular Vaccines

Table 4. Major Players of Whole-cell Vaccines

Table 5. Global Pertussis Vaccination Sales by Type (2017-2022) & (Units)

Table 6. Global Pertussis Vaccination Sales Market Share by Type (2017-2022)

Table 7. Global Pertussis Vaccination Revenue by Type (2017-2022) & ($ million)

Table 8. Global Pertussis Vaccination Revenue Market Share by Type (2017-2022)

Table 9. Global Pertussis Vaccination Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Pertussis Vaccination Sales by Application (2017-2022) & (Units)

Table 11. Global Pertussis Vaccination Sales Market Share by Application (2017-2022)

Table 12. Global Pertussis Vaccination Revenue by Application (2017-2022)

Table 13. Global Pertussis Vaccination Revenue Market Share by Application (2017-2022)

Table 14. Global Pertussis Vaccination Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Pertussis Vaccination Sales by Company (2020-2022) & (Units)

Table 16. Global Pertussis Vaccination Sales Market Share by Company (2020-2022)

Table 17. Global Pertussis Vaccination Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Pertussis Vaccination Revenue Market Share by Company (2020-2022)

Table 19. Global Pertussis Vaccination Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Pertussis Vaccination Producing Area Distribution and Sales Area

Table 21. Players Pertussis Vaccination Products Offered

Table 22. Pertussis Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Pertussis Vaccination Sales by Geographic Region (2017-2022) & (Units)

Table 26. Global Pertussis Vaccination Sales Market Share Geographic Region (2017-2022)

Table 27. Global Pertussis Vaccination Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Pertussis Vaccination Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Pertussis Vaccination Sales by Country/Region (2017-2022) & (Units)

Table 30. Global Pertussis Vaccination Sales Market Share by Country/Region (2017-2022)

Table 31. Global Pertussis Vaccination Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Pertussis Vaccination Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Pertussis Vaccination Sales by Country (2017-2022) & (Units)

Table 34. Americas Pertussis Vaccination Sales Market Share by Country (2017-2022)

Table 35. Americas Pertussis Vaccination Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Pertussis Vaccination Revenue Market Share by Country (2017-2022)

Table 37. Americas Pertussis Vaccination Sales by Type (2017-2022) & (Units)

Table 38. Americas Pertussis Vaccination Sales Market Share by Type (2017-2022)

Table 39. Americas Pertussis Vaccination Sales by Application (2017-2022) & (Units)

Table 40. Americas Pertussis Vaccination Sales Market Share by Application (2017-2022)

Table 41. APAC Pertussis Vaccination Sales by Region (2017-2022) & (Units)

Table 42. APAC Pertussis Vaccination Sales Market Share by Region (2017-2022)

Table 43. APAC Pertussis Vaccination Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Pertussis Vaccination Revenue Market Share by Region (2017-2022)

Table 45. APAC Pertussis Vaccination Sales by Type (2017-2022) & (Units)

Table 46. APAC Pertussis Vaccination Sales Market Share by Type (2017-2022)

Table 47. APAC Pertussis Vaccination Sales by Application (2017-2022) & (Units)

Table 48. APAC Pertussis Vaccination Sales Market Share by Application (2017-2022)

Table 49. Europe Pertussis Vaccination Sales by Country (2017-2022) & (Units)

Table 50. Europe Pertussis Vaccination Sales Market Share by Country (2017-2022)

Table 51. Europe Pertussis Vaccination Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Pertussis Vaccination Revenue Market Share by Country (2017-2022)

Table 53. Europe Pertussis Vaccination Sales by Type (2017-2022) & (Units)

Table 54. Europe Pertussis Vaccination Sales Market Share by Type (2017-2022)

Table 55. Europe Pertussis Vaccination Sales by Application (2017-2022) & (Units)

Table 56. Europe Pertussis Vaccination Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Pertussis Vaccination Sales by Country (2017-2022) & (Units)

Table 58. Middle East & Africa Pertussis Vaccination Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Pertussis Vaccination Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Pertussis Vaccination Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Pertussis Vaccination Sales by Type (2017-2022) & (Units)

Table 62. Middle East & Africa Pertussis Vaccination Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Pertussis Vaccination Sales by Application (2017-2022) & (Units)

Table 64. Middle East & Africa Pertussis Vaccination Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Pertussis Vaccination

Table 66. Key Market Challenges & Risks of Pertussis Vaccination

Table 67. Key Industry Trends of Pertussis Vaccination

Table 68. Pertussis Vaccination Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Pertussis Vaccination Distributors List

Table 71. Pertussis Vaccination Customer List

Table 72. Global Pertussis Vaccination Sales Forecast by Region (2023-2028) & (Units)

Table 73. Global Pertussis Vaccination Sales Market Forecast by Region

Table 74. Global Pertussis Vaccination Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Pertussis Vaccination Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Pertussis Vaccination Sales Forecast by Country (2023-2028) & (Units)

Table 77. Americas Pertussis Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Pertussis Vaccination Sales Forecast by Region (2023-2028) & (Units)

Table 79. APAC Pertussis Vaccination Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Pertussis Vaccination Sales Forecast by Country (2023-2028) & (Units)

Table 81. Europe Pertussis Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Pertussis Vaccination Sales Forecast by Country (2023-2028) & (Units)

Table 83. Middle East & Africa Pertussis Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Pertussis Vaccination Sales Forecast by Type (2023-2028) & (Units)

Table 85. Global Pertussis Vaccination Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Pertussis Vaccination Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Pertussis Vaccination Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Pertussis Vaccination Sales Forecast by Application (2023-2028) & (Units)

Table 89. Global Pertussis Vaccination Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Pertussis Vaccination Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Pertussis Vaccination Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi Pasteur Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Pasteur Pertussis Vaccination Product Offered

Table 94. Sanofi Pasteur Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. Sanofi Pasteur Main Business

Table 96. Sanofi Pasteur Latest Developments

Table 97. GSK Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 98. GSK Pertussis Vaccination Product Offered

Table 99. GSK Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. GSK Main Business

Table 101. GSK Latest Developments

Table 102. Mitsubishi Tanabe Pharma Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 103. Mitsubishi Tanabe Pharma Pertussis Vaccination Product Offered

Table 104. Mitsubishi Tanabe Pharma Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Mitsubishi Tanabe Pharma Main Business

Table 106. Mitsubishi Tanabe Pharma Latest Developments

Table 107. KM Biologics Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 108. KM Biologics Pertussis Vaccination Product Offered

Table 109. KM Biologics Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. KM Biologics Main Business

Table 111. KM Biologics Latest Developments

Table 112. Wuhan Institute of Biological Products Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 113. Wuhan Institute of Biological Products Pertussis Vaccination Product Offered

Table 114. Wuhan Institute of Biological Products Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. Wuhan Institute of Biological Products Main Business

Table 116. Wuhan Institute of Biological Products Latest Developments

Table 117. Walvax Biotechnology Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 118. Walvax Biotechnology Pertussis Vaccination Product Offered

Table 119. Walvax Biotechnology Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. Walvax Biotechnology Main Business

Table 121. Walvax Biotechnology Latest Developments

Table 122. Chengdu Institute of Biological Products Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 123. Chengdu Institute of Biological Products Pertussis Vaccination Product Offered

Table 124. Chengdu Institute of Biological Products Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Chengdu Institute of Biological Products Main Business

Table 126. Chengdu Institute of Biological Products Latest Developments

Table 127. Minhai Biotechnology Basic Information, Pertussis Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 128. Minhai Biotechnology Pertussis Vaccination Product Offered

Table 129. Minhai Biotechnology Pertussis Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Minhai Biotechnology Main Business

Table 131. Minhai Biotechnology Latest Developments

List of Figures

Figure 1. Picture of Pertussis Vaccination

Figure 2. Pertussis Vaccination Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Pertussis Vaccination Sales Growth Rate 2017-2028 (Units)

Figure 7. Global Pertussis Vaccination Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Pertussis Vaccination Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Acellular Vaccines

Figure 10. Product Picture of Whole-cell Vaccines

Figure 11. Global Pertussis Vaccination Sales Market Share by Type in 2021

Figure 12. Global Pertussis Vaccination Revenue Market Share by Type (2017-2022)

Figure 13. Pertussis Vaccination Consumed in 12 Months Below

Figure 14. Global Pertussis Vaccination Market: 12 Months Below (2017-2022) & (Units)

Figure 15. Pertussis Vaccination Consumed in 12 Months Above

Figure 16. Global Pertussis Vaccination Market: 12 Months Above (2017-2022) & (Units)

Figure 17. Global Pertussis Vaccination Sales Market Share by Application (2017-2022)

Figure 18. Global Pertussis Vaccination Revenue Market Share by Application in 2021

Figure 19. Pertussis Vaccination Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Pertussis Vaccination Revenue Market Share by Company in 2021

Figure 21. Global Pertussis Vaccination Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Pertussis Vaccination Revenue Market Share by Geographic Region in 2021

Figure 23. Global Pertussis Vaccination Sales Market Share by Region (2017-2022)

Figure 24. Global Pertussis Vaccination Revenue Market Share by Country/Region in 2021

Figure 25. Americas Pertussis Vaccination Sales 2017-2022 (Units)

Figure 26. Americas Pertussis Vaccination Revenue 2017-2022 ($ Millions)

Figure 27. APAC Pertussis Vaccination Sales 2017-2022 (Units)

Figure 28. APAC Pertussis Vaccination Revenue 2017-2022 ($ Millions)

Figure 29. Europe Pertussis Vaccination Sales 2017-2022 (Units)

Figure 30. Europe Pertussis Vaccination Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Pertussis Vaccination Sales 2017-2022 (Units)

Figure 32. Middle East & Africa Pertussis Vaccination Revenue 2017-2022 ($ Millions)

Figure 33. Americas Pertussis Vaccination Sales Market Share by Country in 2021

Figure 34. Americas Pertussis Vaccination Revenue Market Share by Country in 2021

Figure 35. United States Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Pertussis Vaccination Sales Market Share by Region in 2021

Figure 40. APAC Pertussis Vaccination Revenue Market Share by Regions in 2021

Figure 41. China Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Pertussis Vaccination Sales Market Share by Country in 2021

Figure 48. Europe Pertussis Vaccination Revenue Market Share by Country in 2021

Figure 49. Germany Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Pertussis Vaccination Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Pertussis Vaccination Revenue Market Share by Country in 2021

Figure 56. Egypt Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Pertussis Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Pertussis Vaccination in 2021

Figure 62. Manufacturing Process Analysis of Pertussis Vaccination

Figure 63. Industry Chain Structure of Pertussis Vaccination

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390